相似文献
1
Kunjin virus replicon-based vaccines expressing Ebola virus glycoprotein GP protect the guinea pig against lethal Ebola virus infection.
J Infect Dis. 2011 Nov;204 Suppl 3(Suppl 3):S1060-5. doi: 10.1093/infdis/jir347.
2
A Kunjin Replicon Virus-like Particle Vaccine Provides Protection Against Ebola Virus Infection in Nonhuman Primates.
J Infect Dis. 2015 Oct 1;212 Suppl 2(Suppl 2):S368-71. doi: 10.1093/infdis/jiv019. Epub 2015 Mar 2.
3
Attenuated Human Parainfluenza Virus Type 1 Expressing Ebola Virus Glycoprotein GP Administered Intranasally Is Immunogenic in African Green Monkeys.
J Virol. 2017 Apr 28;91(10). doi: 10.1128/JVI.02469-16. Print 2017 May 15.
4
Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
J Virol. 2018 May 14;92(11). doi: 10.1128/JVI.00363-18. Print 2018 Jun 1.
5
An Adenovirus Vaccine Expressing Ebola Virus Variant Makona Glycoprotein Is Efficacious in Guinea Pigs and Nonhuman Primates.
J Infect Dis. 2016 Oct 15;214(suppl 3):S326-S332. doi: 10.1093/infdis/jiw250. Epub 2016 Aug 4.
6
Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge.
PLoS One. 2016 Sep 13;11(9):e0162446. doi: 10.1371/journal.pone.0162446. eCollection 2016.
7
Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy.
J Infect Dis. 2011 Nov;204 Suppl 3(Suppl 3):S1066-74. doi: 10.1093/infdis/jir348.
8
Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.
J Virol. 2017 May 12;91(11). doi: 10.1128/JVI.00343-17. Print 2017 Jun 1.
9
Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus.
Vaccine. 2000 Aug 15;19(1):142-53. doi: 10.1016/s0264-410x(00)00113-4.
10
Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents.
Vaccine. 2014 Sep 29;32(43):5722-9. doi: 10.1016/j.vaccine.2014.08.028. Epub 2014 Aug 27.
引用本文的文献
1
Replicon RNA vaccines: design, delivery, and immunogenicity in infectious diseases and cancer.
J Hematol Oncol. 2025 Apr 17;18(1):43. doi: 10.1186/s13045-025-01694-2.
2
Development of Zika Virus Mini-Replicon Based Single-Round Infectious Particles as Gene Delivery Vehicles.
Viruses. 2023 Aug 18;15(8):1762. doi: 10.3390/v15081762.
3
Enhanced Seroconversion to West Nile Virus Proteins in Mice by West Nile Kunjin Replicon Virus-like Particles Expressing Glycoproteins from Crimean-Congo Hemorrhagic Fever Virus.
Pathogens. 2022 Feb 10;11(2):233. doi: 10.3390/pathogens11020233.
4
A Yellow Fever 17D Virus Replicon-Based Vaccine Platform for Emerging Coronaviruses.
Vaccines (Basel). 2021 Dec 16;9(12):1492. doi: 10.3390/vaccines9121492.
5
Middle East respiratory syndrome coronavirus vaccine based on a propagation-defective RNA replicon elicited sterilizing immunity in mice.
Proc Natl Acad Sci U S A. 2021 Oct 26;118(43). doi: 10.1073/pnas.2111075118.
6
Development of a Multivalent Kunjin Virus Reporter Virus-Like Particle System Inducing Seroconversion for Ebola and West Nile Virus Proteins in Mice.
Microorganisms. 2020 Nov 29;8(12):1890. doi: 10.3390/microorganisms8121890.
7
Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus.
Front Immunol. 2018 Aug 10;9:1803. doi: 10.3389/fimmu.2018.01803. eCollection 2018.
8
Production of Ebola virus-like particles in Drosophila melanogaster Schneider 2 cells.
J Virol Methods. 2018 Nov;261:156-159. doi: 10.1016/j.jviromet.2018.08.016. Epub 2018 Aug 23.
9
Latest development on RNA-based drugs and vaccines.
Future Sci OA. 2018 May 4;4(5):FSO300. doi: 10.4155/fsoa-2017-0151. eCollection 2018 Jun.
10
Ebola and Marburg virus vaccines.
Virus Genes. 2017 Aug;53(4):501-515. doi: 10.1007/s11262-017-1455-x. Epub 2017 Apr 26.
本文引用的文献
1
Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs.
J Virol. 2010 Mar;84(6):3004-15. doi: 10.1128/JVI.02459-09. Epub 2010 Jan 13.
2
Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins.
J Virol. 2009 Sep;83(18):9596-601. doi: 10.1128/JVI.00784-09. Epub 2009 Jul 8.
3
Production of antibodies against multipass membrane proteins expressed in human tumor cells using dendritic cell immunization.
J Biomed Biotechnol. 2009;2009:673098. doi: 10.1155/2009/673098. Epub 2009 Apr 15.
4
Replication-deficient ebolavirus as a vaccine candidate.
J Virol. 2009 Apr;83(8):3810-5. doi: 10.1128/JVI.00074-09. Epub 2009 Feb 11.
5
A Kunjin replicon vector encoding granulocyte macrophage colony-stimulating factor for intra-tumoral gene therapy.
Gene Ther. 2009 Feb;16(2):190-9. doi: 10.1038/gt.2008.169. Epub 2008 Dec 18.
6
A DNA vaccine for the prevention of Ebola virus infection.
Curr Opin Mol Ther. 2008 Jun;10(3):285-93.
7
Evaluation of recombinant Kunjin replicon SIV vaccines for protective efficacy in macaques.
Virology. 2008 May 10;374(2):528-34. doi: 10.1016/j.virol.2008.01.006. Epub 2008 Feb 12.
8
Ebola virus inactivation with preservation of antigenic and structural integrity by a photoinducible alkylating agent.
J Infect Dis. 2007 Nov 15;196 Suppl 2:S276-83. doi: 10.1086/520605.
9
A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge.
J Virol. 2006 Mar;80(5):2267-79. doi: 10.1128/JVI.80.5.2267-2279.2006.
10
Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications.
Expert Opin Biol Ther. 2006 Feb;6(2):135-45. doi: 10.1517/14712598.6.2.135.
Zotero 插件